Nebulized Hypertonic Saline for Bronchiolitis

Status Completed

Clinical Trial Summary

In randomized controlled trials, the use of nebulized hypertonic saline in acute bronchiolitis has been reported to improve respiratory distress scores, to reduce length of hospital stay and to show a trend towards lower hospitalization rates.

The investigators aim to verify by an observational study if the rate of hospital admission and the length of hospital stay of infants presenting to the emergency department (ED) with bronchiolitis decreases after the inclusion of 5.85% nebulized hypertonic saline in the treatment strategy of the ED and hospitalization wards.

The investigators will assess the evolution of hospital admission rates and the length of hospital stay in two hospitals that use 5.85% nebulized hypertonic saline for the treatment of bronchiolitis and in two hospital that do not use these nebulizations. If nebulized hypertonic saline is effective in this setting, then the hospitalization rates and length of stay should be lower during the year of hypertonic saline use compared to two previous years when this therapy was not used. These parameters would not be modified in centers that do not use hypertonic saline.

Clinical Trial Description

This is a before-after observational study designed to compare the results in terms of hospitalization rate and length of hospital stay between a period when nebulized hypertonic saline was included in the treatment of bronchiolitis in infants versus the two previous years when this therapy was not used in two hospitals. There will not be any randomization.

Physicians have been instructed on the use of hypertonic saline for moderate and severe bronchiolitis in infants but its totally up to them whether to use this nebulization for each particular patient. Two other hospital where nebulized hypertonic saline has never been used and will not be used during the next bronchiolitis epidemics will be the control centers.

The study comprises two periods, one prospective starting on November 2011 and ending in March 2012 and one retrospective including the two previous bronchiolitis epidemics, November 2009-March 2012 and November 2010-March 2011.

During the prospective period a standardized assessment of the respiratory status of each infant will be carried out before and after each hypertonic saline nebulization. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Bronchiolitis

Clinical Trial Details

NCT number	NCT01460524
Study type	Observational
Source	Hôpital Armand Trousseau
Contact
Status	Completed
Phase	N/A
Start date	November 2011
Completion date	May 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04989114` - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis	N/A
Recruiting	`NCT06016244` - Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial	N/A
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Recruiting	`NCT02366715` - Treatment Of Bronchiolitis With Heated Humidified High Flow Nasal Cannula - Prospective And Retrospective Research	Phase 3
Terminated	`NCT02219334` - Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study	N/A
Recruiting	`NCT01944995` - Work of Breathing in Nasal CPAP Versus High Flow Nasal Prong in Infants With Severe Acute Bronchiolitis	N/A
Terminated	`NCT02834819` - Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis	N/A
Terminated	`NCT01757496` - Cough Assist in Bronchiolitis	N/A
Not yet recruiting	`NCT01414322` - Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients	N/A
Completed	`NCT00369759` - An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants	N/A
Completed	`NCT00347880` - Atrial and Brain Natriuretic Peptides in Bronchiolitis	Phase 1
Recruiting	`NCT05548036` - A Feasibility RCT of Aerobika Verses ACBT in People With COPD	N/A
Active, not recruiting	`NCT04302207` - The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study	N/A
Completed	`NCT02858531` - Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
Withdrawn	`NCT05994183` - The Bronchiolitis in Hospitalized Infants Study	Early Phase 1
Terminated	`NCT03614507` - Automation Oxygen Flow Titration in Spontaneously Breathing Infants	N/A
Completed	`NCT02856165` - High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis	N/A
Recruiting	`NCT05909566` - Respiratory Support and Treatment for Efficient and Cost-Effective Care	N/A
Recruiting	`NCT04437641` - Impact of Pediatrician Intervention on the Smoking Habits of Parents of Sick Children
Not yet recruiting	`NCT06083077` - Chest and Abdominal Wall Strapping in Infant With Bronchiolitis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.